Booster Dose of sIPV Co-administered With MMR and HepA-I.

计划入组 889 人 · 首次发布于 2024 年 6 月 4 日

Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)

计划入组 175 人 · 首次发布于 2006 年 4 月 5 日

Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

计划入组 1,516 人 · 首次发布于 2020 年 7 月 9 日

Nateplase

MMR vaccine

68GaNOTA-Anti-MMR-VHH2

CMR SRL

Italy

MYR GmbH

Germany

Hospital del Mar

Spain

Nivolumab and Relatlimab Show Promise in MMR-Deficient Colon Cancer

FDA Approves VENTANA MMR RxDx Panel as Companion Diagnostic for Dostarlimab in Endometrial Cancer

Agilent's MMR IHC Panel PharmDx Receives FDA Approval as Companion Diagnostic for Colorectal Cancer Immunotherapy